Literature DB >> 15174754

Diagnosis of chronic rhinosinusitis.

Donald C Lanza1.   

Abstract

Chronic rhinosinusitis is a multifactorial disease defined as inflammation of the nasal cavity and paranasal sinuses with a history of at least 12 weeks in duration. The major symptoms include facial pressure or pain, nasal obstruction, discharge or purulence, and hyposmia or anosmia. The minor symptoms include fever, halitosis, fatigue, and dental pain. Microorganisms play a significant role in the persistence and origination of the inflammatory process, although the exact role of these organisms in the pathogenesis of chronic rhinosinusitis is unclear. The clinical diagnosis relies heavily on the patient history and physical examination, which may include nasal endoscopy and computed tomography. Diagnostic techniques are here reviewed.

Entities:  

Mesh:

Year:  2004        PMID: 15174754     DOI: 10.1177/00034894041130s504

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol Suppl        ISSN: 0096-8056


  11 in total

Review 1.  Radiological imaging of inflammatory lesions in the nasal cavity and paranasal sinuses.

Authors:  H B Eggesbø
Journal:  Eur Radiol       Date:  2006-01-04       Impact factor: 5.315

2.  Appropriate interslice gap for screening coronal paranasal sinus tomography for mucosal thickening.

Authors:  Can Alper Cagici; Cuneyt Yilmazer; Cem Hurcan; Cem Ozer; Fulya Ozer
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-08-08       Impact factor: 2.503

3.  Outcome of endoscopic sinus surgery in patients with symptomatic chronic rhinosinusitis with minimal changes on computerised tomography.

Authors:  A Chakravarti; Shakuntala Naglot; Rajiv Dhawan
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-06-14

4.  Correlation of Nasal Endoscopy and Computed Tomography Scan Findings in Adult Patients With Chronic Rhinosinusitis.

Authors:  Sylvia C Uwaneme; Chinyere N Asoegwu; Vincent A Adekoya; Clement C Nwawolo
Journal:  J West Afr Coll Surg       Date:  2022-06-08

Review 5.  Rhinosinusitis: Establishing definitions for clinical research and patient care.

Authors:  Eli O Meltzer; Daniel L Hamilos; James A Hadley; Donald C Lanza; Bradley F Marple; Richard A Nicklas; Claus Bachert; James Baraniuk; Fuad M Baroody; Michael S Benninger; Itzhak Brook; Badrul A Chowdhury; Howard M Druce; Stephen Durham; Berrylin Ferguson; Jack M Gwaltney; Michael Kaliner; David W Kennedy; Valerie Lund; Robert Naclerio; Ruby Pawankar; Jay F Piccirillo; Patricia Rohane; Ronald Simon; Raymond G Slavin; Alkis Togias; Ellen R Wald; S James Zinreich
Journal:  Otolaryngol Head Neck Surg       Date:  2004-12       Impact factor: 3.497

Review 6.  Rhinosinusitis: establishing definitions for clinical research and patient care.

Authors:  Eli O Meltzer; Daniel L Hamilos; James A Hadley; Donald C Lanza; Bradley F Marple; Richard A Nicklas; Claus Bachert; James Baraniuk; Fuad M Baroody; Michael S Benninger; Itzhak Brook; Badrul A Chowdhury; Howard M Druce; Stephen Durham; Berrylin Ferguson; Jack M Gwaltney; Michael Kaliner; David W Kennedy; Valerie Lund; Robert Naclerio; Ruby Pawankar; Jay F Piccirillo; Patricia Rohane; Ronald Simon; Raymond G Slavin; Alkis Togias; Ellen R Wald; S James Zinreich
Journal:  J Allergy Clin Immunol       Date:  2004-12       Impact factor: 10.793

7.  Halitosis: a new definition and classification.

Authors:  M Aydin; C N Harvey-Woodworth
Journal:  Br Dent J       Date:  2014-07-11       Impact factor: 1.626

8.  PAEDIATRIC OTORHINOLARYNGOLOGICAL PRESENTATION OF HALITOSIS IN A DEVELOPING COUNTRY.

Authors:  A W Adegbiji; T G Olajide; A G Olusola; F Olatoke; C C Nwawolo
Journal:  J West Afr Coll Surg       Date:  2017 Oct-Dec

Review 9.  Halitosis: the multidisciplinary approach.

Authors:  Curd M L Bollen; Thomas Beikler
Journal:  Int J Oral Sci       Date:  2012-06       Impact factor: 6.344

Review 10.  Treating the immunocompetent patient who presents with an upper respiratory infection: pharyngitis, sinusitis, and bronchitis.

Authors:  Perry D Mostov
Journal:  Prim Care       Date:  2007-03       Impact factor: 2.907

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.